WallStreetZenWallStreetZen

NASDAQ: TRAX
First Tracks Biotherapeutics Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
First Tracks Biotherapeutics earnings were -$166.1M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest TRAX earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TRAX reported annual earnings of -$166.1M, with 1.5% growth.

TRAX earnings history

Current Revenue
$0.0
Current Earnings
-$166.1M
Current Profit Margin
0%

TRAX Return on Equity

Current Company
-48.9%
Current Industry
28.9%
Current Market
28.9%

TRAX Return on Assets

Current Company
-43%
Current Industry
14.2%

Be the first to know when TRAX announces earnings.

TRAX Return on Capital Employed

Current Company
-55.45%
Current Industry
16.9%

First Tracks Biotherapeutics Earnings Reports & History FAQ

What were First Tracks Biotherapeutics's earnings last quarter?

First Tracks Biotherapeutics (NASDAQ: TRAX) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total TRAX earnings for the quarter were N/A. In the same quarter last year, First Tracks Biotherapeutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy First Tracks Biotherapeutics stock.

Is First Tracks Biotherapeutics profitable or losing money?

As of the last First Tracks Biotherapeutics earnings report, First Tracks Biotherapeutics is currently losing money. First Tracks Biotherapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$166.09 million, a 1.46% increase year over year.

What was TRAX's earnings growth in the past year?

As of First Tracks Biotherapeutics's earnings date in Q2 2026, First Tracks Biotherapeutics's earnings has grown year over year. TRAX earnings in the past year totalled -$166.09 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.